Active and passive smoking behaviour and cessation plans of patients with Crohn's disease and ulcerative colitis

Dijkstra, Arie; Albersnagel, Frans A.; Kleibeuker, Jan H.; Dijkstra, Gerard

doi:10.1016/j.crohns.2009.09.005

Cited by 26 publications

(16 citation statements)

References 33 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Our IBD population had a higher prevalence of EIMs than has often been reported by others [11,21]. In this study group, 50% of patients were affected with one or more EIMs (54% CD, 43% UC).…”

Section: Discussioncontrasting

confidence: 44%

Extraintestinal Manifestations of Inflammatory Bowel Disease and the Influence of Smoking

Roberts

Shesh²,

Pan³

et al. 2014

Digestion

View full text Add to dashboard Cite

Aims: To define the number/frequency of organ systems affected by extraintestinal manifestations (EIMs), to identify factors affecting the clinical course of inflammatory bowel disease (IBD) and EIM development, and to determine the impact of smoking, disease duration and location on the diagnosis of EIMs in Crohn's disease (CD) and ulcerative colitis (UC). Methods: IBD patients were derived from a single university colorectal surgery practice. Smoking data were obtained through a modified Behavioral Risk Factor Surveillance System survey. The frequencies of arthritis/arthralgia, primary sclerosing cholangitis (PSC), ocular and cutaneous EIMs were determined. Results: Of the 757 patients evaluated (CD 488, UC 269), 50% had ≥1 EIM. Arthritis/arthralgia, cutaneous and ocular EIMs were significantly higher in frequency in CD compared to UC patients. Prolonged disease duration was associated with increased prevalence of arthritis/arthralgia in IBD (p ≤ 0.001) as well as PSC (p = 0.049), ocular (p = 0.030) and cutaneous (p = 0.009) EIMs in CD. Disease location affected the occurrence of EIMs in CD. Smoking appeared to increase the prevalence of ocular EIMs in UC (p = 0.026). Conclusion: Arthritis/arthralgia, cutaneous and ocular EIMs occurred in a significantly higher proportion of CD patients. CD patients with longer disease duration had a significantly higher prevalence of PSC, ocular and cutaneous EIMs. Smoking was found to increase ocular EIMs in UC.

show abstract

Section: Discussioncontrasting

confidence: 44%

Extraintestinal Manifestations of Inflammatory Bowel Disease and the Influence of Smoking

Roberts

Shesh²,

Pan³

et al. 2014

Digestion

View full text Add to dashboard Cite

show abstract

“…We confirmed some known facts in our IBD population. 25 First, UC patients were more frequent former smokers at diagnosis, and this in contrast to a rather avid CD smoking population. Secondly, as also shown by Nunes et al, our smoking IBD population was not more nicotine dependent compared to our non-IBD control population.…”

Section: Discussionmentioning

confidence: 93%

Smoking behaviour and knowledge of the health effects of smoking in patients with inflammatory bowel disease

Bie

Ballet

Hendriks

et al. 2015

Aliment Pharmacol Ther

View full text Add to dashboard Cite

show abstract

“…1,31 The prevalence of smoking is also remarkably higher in RHS patients (70.0%) compared with IBD+HS patients (29.9%). 31,33 HS patients with IBD (35.8%) are more likely than those without IBD (15.0%) to have quit smoking. The explanation for the difference in smoking behavior might be that the majority of IBD +HS patients suffer from CD.…”

Section: Discussionmentioning

confidence: 96%

Identification of Clinical and Genetic Parameters Associated with Hidradenitis Suppurativa in Inflammatory Bowel Disease

Janse¹,

Koldijk²,

Spekhorst

et al. 2016

Inflammatory Bowel Diseases

Self Cite

View full text Add to dashboard Cite

HS is present in 6.8% to 10.6% of IBD patients. Co-morbid HS is associated with an early onset of IBD in which anti-tumor necrosis factor-α therapy and surgical resections are often needed. We identified a suggestive protective association with ELOVL7 and suggestive risk association with the genes SULT1B1 and SULT1E1 for HS, in the context of IBD. These genetic associations need further exploration and replication in additional independent cohorts.

show abstract

Active and passive smoking behaviour and cessation plans of patients with Crohn's disease and ulcerative colitis

Cited by 26 publications

References 33 publications

Extraintestinal Manifestations of Inflammatory Bowel Disease and the Influence of Smoking

Extraintestinal Manifestations of Inflammatory Bowel Disease and the Influence of Smoking

Smoking behaviour and knowledge of the health effects of smoking in patients with inflammatory bowel disease

Identification of Clinical and Genetic Parameters Associated with Hidradenitis Suppurativa in Inflammatory Bowel Disease

Contact Info

Product

Resources

About